Clinical Trial Update: Biomarkers in DNA Samples From Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Gemtuzumab Ozogamicin

View source ↗

Summary

A completed study from the Children's Oncology Group evaluating biomarkers in DNA samples from younger patients with newly diagnosed acute myeloid leukemia trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Mylotarg (gemtuzumab ozogamicin)

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Status: COMPLETED